e r u v i t e u w F World News 3 May 2030 09.30 ET Blue World In 2030, organisations Drumhum Inc leads the pack in the use of cognitive-enhancing drugs in the workplace as begin to realise the companies begin to realise their benefits. benefits of human enhancement in the workplace. Drumhum Inc, the first large employer to Cognitalin, a modified methylphenidate An online news report offer cognitive‑enhancing medication to its substitute developed by PharmaXcog, increases from 2030 details the employees, says it has seen a 4% increase in concentration and enhances memory function first large-scale use of productivity during the first three months of by increasing the synaptic concentration cognitive‑enhancing the financial year. of the neurotransmitters dopamine and drugs. noradrenaline by blocking their reuptake and Drumhum offered the methylpehnidate‑based stimulating the prefrontal cortical network. drug Cognitalin, the first cognitive enhancer It was licenced for non‑medical use in 2027 to be mass produced specifically for use in the following the publication of the Ethical Charter workplace, to its employees on a voluntary on Workplace Enhancement. basis at the beginning of the year. “The programme,” said Nancy Cole, the company’s Drumhum measured the performance Head of People Performance, “was closely of the Cognitalin group against a control monitored; it was also heavily oversubscribed, group of employees of similar experience with more than 73% of Drumhum’s 3,000 and demographics, who continued with workers based in the US volunteering to Drumhum’s standard programme of gaming‑ take part.” based cognitive training. “The group taking Cognitalin,” said Cole, “proved significantly more productive, completing a complex coding exercise around 10% more quickly than the control group – with 4% fewer errors.” Read more 19